In a recent claim construction Order, Chief Judge Gregory M. Sleet construed the following terms of U.S. Patent No. RE41,555, entitled “Antibody purification:”
“selectively eluting [the monomeric IgG antibody] from the support” and “the
antibody selectively eluted;”
“monomeric IgG antibody”
GlaxoSmithKline LLC v. Genentech, Inc., C.A. No. 10-799-GMS (D. Del. Aug. 22, 2013).